Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
Albert-Vartanian, A., Boyd, M. R., Hall, A. L., Morgado, S. J., Nguyen, E., Nguyen, V. P. H., Patel, S. P., Russo, L. J., Shao, A. J., Raffa, R. B.Том:
41
Мова:
english
Журнал:
Journal of Clinical Pharmacy and Therapeutics
DOI:
10.1111/jcpt.12404
Date:
August, 2016
Файл:
PDF, 746 KB
english, 2016